← SynDRA
REVEFENACIN
SynDRA canonical compound SYN0038581 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx |
|---|
| Primary target(s) | CHRM3 |
|---|
| Mechanism of action | cholinergic receptor antagonist |
|---|
All known targets
- CHRM3
- CHRM1
- CHRM2
- CHRM4
- CHRM5
Mechanisms of action (all sources)
- CHRM3 ANTAGONIST
- Muscarinic acetylcholine receptor M3 antagonist
- CHRM1 ANTAGONIST
- CHRM2 ANTAGONIST
- CHRM4 ANTAGONIST
- CHRM5 ANTAGONIST
- cholinergic receptor antagonist
Drug classes
- Cholinergic Antagonists
- Anticholinergic
ATC classes
- R03B · OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS
Cross-references
Synonyms
- yupelri
- TD-4208
- GSK 1160724
- Revefenacine
- Revefenacina
- GSK-1160724
- GSK1160724
- Yupelri
- UNII-G2AE2VE07O
- G2AE2VE07O
- Revefenacin [INN]
- Revefenacin [WHO-DD]
- Revefenacin [USAN:INN]
- Revefenacin (USAN/INN)
- SCHEMBL356480
- EX-A1722
- DB11855
- CS-7743
- HY-15851
- D10978
- revefenacina
- revefenacine
- revefenacinum
- RefChem:57759
- R03BB08
- DTXCID801513351
- Yupelri (TN)
- MFCD28386316
- Revefenacin (Standard)
- REVEFENACIN [MI]
- REVEFENACIN [USAN]
- Revefenacin;GSK1160724
- orb1299860
- GTPL10129
- REVEFENACIN [ORANGE BOOK]
- C35H43N5O4
- GLXC-23321
- HMS3886K17
Reported adverse events
- Back pain
- Cough
- Dry mouth
- Headache
- Nasopharyngitis
- Upper respiratory tract infection
Look up REVEFENACIN in the interactive SynDRA portal →